Flavio Paterno, MD
Transplant Surgery · Newark, NJNPI 1760666507
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.9%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Intuitive Surgical at 44.4% of the total. Reporting peaked in 2022 at $5,173 and has fallen 72.0% since, to $1,449 in 2025.
Across 42 payments — averaging $343.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Novartis$3K
- Johnson & Johnson$3K
- Davol Inc.$1K
- Organ Recovery Systems, Inc.$978
- Echosens North America, Inc.$201
- plus $323 from 2 others
What the payments were for
- Consulting fees$5,18536%
- Travel & lodging$2,34916%
- Food & beverage$2,87520%
- Education$4,00028%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $6,401 |
| Novartis | 2 | $2,660 |
| Johnson & Johnson | 1 | $2,525 |
| Davol Inc. | 13 | $1,339 |
| Organ Recovery Systems, Inc. | 3 | $978 |
| Echosens North America, Inc. | 1 | $201 |
| Dilon Technologies, Inc. | 1 | $173 |
| Histosonics, Inc. | 1 | $150 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,000
- Echelon Flex$2,525
- VISTASEAL$2,525
- Da Vinci Surgical System$2,077
- FibroScan$201
- HemoBlast Bellows$173
- Phasix Mesh$163
How this compares
Too few transplant surgery providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 15 | $50 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Newark
- James GuarreraNewark$1M
- Arpit AminNewark$5K
- Keri LunsfordNewark$4K
- Adrian FisherNewark$1K
- Michael GoldsteinHackensack$158K
- Caroline RochonCherry Hill$8K
- Nasser YoussefCamden$4K
- Ronald PelletierNew Brunswick$3K
- Samuel SultanHackensack$3K
- Ely SebastianCamden$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.